Novavax
NVAX
7.47
-0.25
-3.24%
Novavax
US · NVAX
#2865 by market cap
Listed 1970
7.47
-0.25
-3.24%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:01
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 6 in the most recent period (2026/Q3).
- Total institutional ownership fell 3.1 percentage points.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 68.45% -3.05pp
- Institutions
- 304 -6
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund38.67%
Hedge Fund19.09%
Public Company8.92%
Private Company0.88%
Individual/Insider0.79%
Government Pension Fund0.36%
Corporate Pension Plan0.24%
Insurance Company0.21%
Other30.76%
Top holders as of 2026-09-30
BlackRock
9.45% · 15.59M sh
Shah Capital Management, Inc
6.39% · 10.54M sh
State Street Global Advisors
5.35% · 8.83M sh
Vanguard Portfolio Management, LLC
4.39% · 7.25M sh
Vanguard Capital Management, LLC
4.38% · 7.23M sh
Sanofi
4.17% · 6.88M sh
D. E. Shaw & Co., L.P.
3.42% · 5.65M sh
Geode Capital Management, LLC
2.56% · 4.23M sh
Two Sigma Investments, LP
2.48% · 4.09M sh
Coatue Management
2.33% · 3.84M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 41 buys · 6 sells
| Name | Role | Stake |
|---|---|---|
| John Jacobs | Chief Executive Officer | 0.19% |
| Elaine O'Hara | Chief Strategy Officer | 0.08% |
| James Kelly | Chief Financial Officer | 0.08% |
| John Trizzino | Former President | 0.07% |
| Mark Casey | Executive Vice President | 0.05% |
| David Mott | Chairperson | 0.05% |
| Richard Douglas | Independent Director | 0.04% |
| Gregg Alton | Independent Director | 0.03% |
| Richard Rodgers | Independent Director | 0.03% |
| Margaret McGlynn | Independent Vice Chairman of the Board of Directors | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-06-19 | David Mott | Chairperson | Derivative Exercise and Retained | +18,880 | -- |
| 2026-06-19 | Richard Douglas | Independent Director | Derivative Exercise and Retained | +18,880 | -- |
| 2026-06-19 | Margaret McGlynn | Independent Vice Chairman of the Board of Directors | Derivative Exercise and Retained | +18,880 | -- |
| 2026-06-19 | Gregg Alton | Independent Director | Derivative Exercise and Retained | +18,880 | -- |
| 2026-06-19 | Rachel King | Independent Director | Derivative Exercise and Retained | +18,880 | -- |
| 2026-06-19 | Richard Rodgers | Independent Director | Derivative Exercise and Retained | +18,880 | -- |
| 2026-06-17 | David Mott | Chairperson | Other Derivative Acquisition | +14,180 | -- |
| 2026-06-17 | David Mott | Chairperson | Other Derivative Acquisition | +21,270 | $9.13 |
| 2026-06-17 | Richard Douglas | Independent Director | Other Derivative Acquisition | +14,180 | -- |
| 2026-06-17 | Richard Douglas | Independent Director | Other Derivative Acquisition | +21,270 | $9.13 |
| 2026-06-17 | Margaret McGlynn | Independent Vice Chairman of the Board of Directors | Other Derivative Acquisition | +14,180 | -- |
| 2026-06-17 | Margaret McGlynn | Independent Vice Chairman of the Board of Directors | Other Derivative Acquisition | +21,270 | $9.13 |
| 2026-06-17 | Gregg Alton | Independent Director | Other Derivative Acquisition | +14,180 | -- |
| 2026-06-17 | Gregg Alton | Independent Director | Other Derivative Acquisition | +21,270 | $9.13 |
| 2026-06-17 | Rachel King | Independent Director | Other Derivative Acquisition | +14,180 | -- |
| 2026-06-17 | Rachel King | Independent Director | Other Derivative Acquisition | +21,270 | $9.13 |
| 2026-06-17 | Richard Rodgers | Independent Director | Other Derivative Acquisition | +14,180 | -- |
| 2026-06-17 | Richard Rodgers | Independent Director | Other Derivative Acquisition | +21,270 | $9.13 |
| 2026-06-17 | John Shiver | Independent Director | Other Derivative Acquisition | +14,180 | -- |
| 2026-06-17 | John Shiver | Independent Director | Other Derivative Acquisition | +21,270 | $9.13 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:01:36 · For reference only, not investment advice and not tailored to your situation.
Novavax discussion 0 comments